Ultragenyx Pharmaceutical Inc.

SUSQUEHANNA INTERNATIONAL GROUP, LLP RARE

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

152,316

Value ($000)

3,503

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	3,503	0.0%	152,316	12/31/2025
2025 Q3	11/14/2025	7,043	0.0%	234,126	9/30/2025
2025 Q2	8/14/2025	2,917	0.0%	80,223	6/30/2025
2025 Q1	5/14/2025	4,362	0.0%	120,460	3/31/2025
2024 Q4	2/14/2025	7,590	0.0%	180,425	12/31/2024
2024 Q3	11/14/2024	6,685	0.0%	120,337	9/30/2024
2024 Q2	8/15/2024	1,022	0.0%	24,871	6/30/2024
2024 Q1	5/7/2024	2,285	0.0%	48,950	3/31/2024
2023 Q4	2/14/2024	1,700	0.0%	35,541	12/31/2023
2023 Q3	11/14/2023	4,530	0.0%	127,057	9/30/2023
2023 Q2	8/11/2023	5,105	0.0%	110,664	6/30/2023
2023 Q1	5/16/2023	2,916	0.0%	72,713	3/31/2023
2022 Q4	2/14/2023	667	0.0%	14,389	12/31/2022
2022 Q3	11/14/2022	3,797	0.0%	91,689	9/30/2022
2022 Q2	8/15/2022	211	0.0%	3,535	6/30/2022
2022 Q1	5/16/2022	1,442	0.0%	19,853	3/31/2022
2021 Q4	2/14/2022	2,301	0.0%	27,361	12/31/2021
2021 Q3	11/15/2021	1,540	0.0%	17,072	9/30/2021
2021 Q2	8/11/2021	9,813	0.0%	102,917	6/30/2021
2021 Q1	5/17/2021	1,062	0.0%	9,323	3/31/2021
2020 Q4	2/16/2021	1,784	0.0%	12,889	12/31/2020
2020 Q3	11/16/2020	1,127	0.0%	13,708	9/30/2020
2020 Q2	8/14/2020	3,276	0.0%	41,882	6/30/2020
2020 Q1	5/15/2020	4,034	0.0%	90,789	3/31/2020
2019 Q4	2/14/2020	2,983	0.0%	69,847	12/31/2019